These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8735095)

  • 81. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
    Busch MP; Kleinman SH; Williams AE; Smith JW; Ownby HE; Laycock ME; Lee LL; Pau CP; Schreiber GB
    Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A comparison of four enzyme immunoassays for the simultaneous detection of HIV-1- and HIV-2-specific antibody.
    Berry NJ; Salker R; Contreras M; Barbara JA; Tedder RS
    J Virol Methods; 1991 Sep; 34(1):91-100. PubMed ID: 1955493
    [TBL] [Abstract][Full Text] [Related]  

  • 83. False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in Thailand.
    Cunningham P; Marriott D; Harris C; Hancock S; Carr A; Cooper D
    J Clin Virol; 2003 Feb; 26(2):163-9. PubMed ID: 12600648
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Screening for acute human immunodeficiency virus infection in Baltimore public testing sites.
    Temkin E; Marsiglia VC; Hague C; Erbelding E
    Sex Transm Dis; 2011 May; 38(5):374-7. PubMed ID: 21183865
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Performance characteristics of the AmpliScreen HIV-1 test, an assay designed for screening plasma mini-pools.
    Yang Y; Wisbeski MH; Mendoza M; Dorf S; Xu D; Nguyen M; Yeh S; Sun R
    Biologicals; 1999 Dec; 27(4):315-23. PubMed ID: 10686058
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
    Tobler LH; Kaufman E; Gefter N; Schable C; Busch MP
    Transfusion; 1997 Sep; 37(9):921-5. PubMed ID: 9308638
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Early diagnosis of primary HIV infections: using a combined screening test (p24 antigen and anti-HIV antibodies)].
    Yerly S; Simon F; Perrin L
    Schweiz Med Wochenschr; 1999 Feb; 129(8):319-22. PubMed ID: 10189669
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of four different antigen-capture assays for the detection of human immunodeficiency virus antigen (HIV-Ag).
    Genesca J; Shih JW; Esteban JI; Alter HJ
    J Acquir Immune Defic Syndr (1988); 1989; 2(2):170-77. PubMed ID: 2649654
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen.
    Blijenberg BG; Eman I; Boevé ER; Mössner E; Uhl W
    Eur J Clin Chem Clin Biochem; 1995 Jun; 33(6):383-92. PubMed ID: 7578619
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Blind comparison of Abbott and Dupont HIV antigen ELISA tests for detecting antigenaemia in asymptomatic human immunodeficiency virus antibody positive homosexual men.
    Shanson DC; Brown KE; Goonesekera S; Gazzard B; Coates AR
    J Clin Pathol; 1990 May; 43(5):420-3. PubMed ID: 2370310
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
    Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Sensitivity of the Multispot HIV-1/HIV-2 rapid test using samples from human immunodeficiency virus type 1-positive individuals with various levels of exposure to highly active antiretroviral therapy.
    O'Connell RJ; Agan BK; Anderson SA; Malia JA; Michael NL
    J Clin Microbiol; 2006 May; 44(5):1831-3. PubMed ID: 16672414
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania.
    Urassa W; Godoy K; Killewo J; Kwesigabo G; Mbakileki A; Mhalu F; Biberfeld G
    J Clin Virol; 1999 Sep; 14(1):25-9. PubMed ID: 10548127
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification.
    van Gemen B; Kievits T; Nara P; Huisman HG; Jurriaans S; Goudsmit J; Lens P
    AIDS; 1993 Nov; 7 Suppl 2():S107-10. PubMed ID: 8161439
    [TBL] [Abstract][Full Text] [Related]  

  • 95. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Kern D; Collins M; Fultz T; Detmer J; Hamren S; Peterkin JJ; Sheridan P; Urdea M; White R; Yeghiazarian T; Todd J
    J Clin Microbiol; 1996 Dec; 34(12):3196-202. PubMed ID: 8940471
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evaluation of a newly developed HIV antigen test.
    Fransen K; Mertens G; Stynen D; Goris A; Nys P; Nkengasong J; Heyndrickx L; Janssens W; van der Groen G
    J Med Virol; 1997 Sep; 53(1):31-5. PubMed ID: 9298729
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion.
    Soroka SD; Granade TC; Candal D; Parekh BS
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):918-21. PubMed ID: 16085908
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Analysis of False-Negative Human Immunodeficiency Virus Rapid Tests Performed on Oral Fluid in 3 International Clinical Research Studies.
    Curlin ME; Gvetadze R; Leelawiwat W; Martin M; Rose C; Niska RW; Segolodi TM; Choopanya K; Tongtoyai J; Holtz TH; Samandari T; McNicholl JM;
    Clin Infect Dis; 2017 Jun; 64(12):1663-1669. PubMed ID: 28369309
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.